The recent TGA decision to defer
its verdict (PD 19 Nov) on the up-scheduling
of codeine-containing
OTC medications conflicts with
rising codeine analgesics misuse, its
devastating consequences and the
recognition that opioid misuse is a
public health concern, according to
ScriptWise ceo, Bee Mohamed.
The above snippet is the first part of an article sent to subscribers in Pharmacy Daily's issue from 10 Dec 15
To see the full story, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 10 Dec 15
